© 2006 HTP Pharmaceuticals All Rights Reserved.   Back to Home	“HTP Pharmaceuticals exists to help busy clinical dermatologists better serve their patients by providing more effective and safer products.”   “I became increasingly aware of reoccurring barrier conditions that require disproportionate amounts of time for busy clinical dermatologists. Some of our patients experience dermatitis everyday. Seborrheic, perioral, psoriasiform, or atopic. Others suffer barrier problems associated with rosacea, or irritation from acne meds. Dermatitis patients need a safe and effective transition steroid product, between uses of stronger prescription steroids. Those with barrier problems associated with rosacea, or irritation and sensitivity commonly associated with the use of acne and other prescription meds., need a safe product that allows a higher opportunity for compliance and tolerance.”   As a result in 2004, Steve Harlan M.D. trademarked the name and concept of Hybrid Transitional Products, HTP's. This is becoming a new class of important products for people with dermatology problems and a separate problem of sensitive skin. In 2004, Dr. Harlan began to assemble the HTP Pharmaceuticals team which is committed to helping busy clinical dermatologists better serve their patients by providing more effective and safer products.   Meet Our Executive Team